NDC 17433-9876 Enemeez

Docusate Sodium Liquid Rectal - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
17433-9876
Proprietary Name:
Enemeez
Non-Proprietary Name: [1]
Docusate Sodium
Substance Name: [2]
Docusate Sodium
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s): [4]
  • Rectal - Administration to the rectum.
  • Labeler Name: [5]
    Enemeez Llc Dba Summit Pharmaceuticals
    Labeler Code:
    17433
    FDA Application Number: [6]
    M007
    Marketing Category: [8]
    OTC MONOGRAPH DRUG -
    Start Marketing Date: [9]
    06-15-2012
    Listing Expiration Date: [11]
    12-31-2025
    Exclude Flag: [12]
    N
    Code Navigator:

    Product Packages

    NDC Code 17433-9876-2

    Package Description: 2 TUBE in 1 CONTAINER / 5 mL in 1 TUBE (17433-9876-0)

    NDC Code 17433-9876-3

    Package Description: 30 TUBE in 1 CONTAINER / 5 mL in 1 TUBE (17433-9876-0)

    Price per Unit: $0.36416 per ML

    NDC Code 17433-9876-5

    Package Description: 5 TUBE in 1 CONTAINER / 5 mL in 1 TUBE (17433-9876-0)

    NDC Code 17433-9876-9

    Package Description: 35 TUBE in 1 CONTAINER / 5 mL in 1 TUBE (17433-9876-0)

    Product Details

    What is NDC 17433-9876?

    The NDC code 17433-9876 is assigned by the FDA to the product Enemeez which is a human over the counter drug product labeled by Enemeez Llc Dba Summit Pharmaceuticals. The generic name of Enemeez is docusate sodium. The product's dosage form is liquid and is administered via rectal form. The product is distributed in 4 packages with assigned NDC codes 17433-9876-2 2 tube in 1 container / 5 ml in 1 tube (17433-9876-0), 17433-9876-3 30 tube in 1 container / 5 ml in 1 tube (17433-9876-0), 17433-9876-5 5 tube in 1 container / 5 ml in 1 tube (17433-9876-0), 17433-9876-9 35 tube in 1 container / 5 ml in 1 tube (17433-9876-0). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Enemeez?

    This medication is used to treat occasional constipation. Some medications and conditions can make constipation more likely. Stool softeners such as docusate are often the first method used for preventing and treating this type of constipation. Docusate is often used when straining to have a bowel movement should be avoided (e.g., after a heart attack or surgery). Docusate is a stool softener. It works by increasing the amount of water the stool absorbs in the gut, making the stool softer and easier to pass.

    What are Enemeez Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • DOCUSATE SODIUM 283 mg/5mL - All-purpose surfactant, wetting agent, and solubilizer used in the drug, cosmetics, and food industries. It has also been used in laxatives and as cerumenolytics. It is usually administered as either the calcium, potassium, or sodium salt.

    Which are Enemeez UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Enemeez Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Enemeez?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".